Alexion Pharmaceuticals Competitors and Similar CompaniesClear all
Alexion Pharmaceuticals's competitors and similar companies include Regeneron Pharmaceuticals, MediWound, Angion Biomedica and Verrica Pharmaceuticals.
 Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. |  Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines. |  MediWound MediWound is a biotechnology company engaged in developing innovative solutions in severe burn and chronic wound care. |  Angion Biomedica Angion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury. |  Verrica Pharmaceuticals Verrica Pharmaceuticals is developing proprietary topical therapies for the treatment of lesional skin diseases such as Verruca vulgaris (common warts and plantar warts) and Molluscum contagiosum. | |
Founding Date | Founding Date 1992 | Founding Date 1988 | Founding Date 2001 | Founding Date 1998 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more | Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more | Locations Yavne, IL HQ Rüsselsheim Am Main, DE Wilmington, US | Locations San Francisco, US HQ Uniondale, US | Locations West Chester, US HQ |
Employees | Employees 10,6006% increase | Employees 15,1068% increase | Employees 111 | Employees 205% increase | Employees 176% increase |
Valuation ($) | Valuation ($) 40.3 b | Valuation ($) 102.2 b | Valuation ($) 196.3 m | Valuation ($) N/A | Valuation ($) 71.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $6.1b (FY, 2020) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $17m (FY, 2025) | Revenue (est.) $2.3m (FY, 2022) | Revenue (est.) $35.6m (FY, 2025) |
Cost of goods | Cost of goods $553.5m (FY, 2020) | Cost of goods N/A | Cost of goods $13.1m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $5.5b (FY, 2020) | Gross profit N/A | Gross profit $4.1m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income $603.4m (FY, 2020) | Net income $4.5b (FY, 2025) | Net income ($23.9m) (FY, 2025) | Net income ($38.8m) (FY, 2022) | Net income ($17.9m) (FY, 2025) |
Operating ⚠ | |||||
Patents (US) | Patents (US) N/A | Patents (US) 31 (FY, 2020) | Patents (US) N/A | Patents (US) 19 (Mar, 2021) | Patents (US) N/A |
Products | Products 5 (Q1, 2021) | Products 11 (FY, 2022) | Products N/A | Products N/A | Products N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 53.9m | Total funding raised N/A | Total funding raised $ 19.7m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Regeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
15,106↑ 8% increase
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
View companyMediWound
HQ
Yavne, IL
Employees
111
MediWound is a biotechnology company engaged in developing innovative solutions in severe burn and chronic wound care.
View companyAngion Biomedica
HQ
San Francisco, US
Employees
20↑ 5% increase
Angion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury.
View companyVerrica Pharmaceuticals
HQ
West Chester, US
Employees
17↑ 6% increase
Verrica Pharmaceuticals is developing proprietary topical therapies for the treatment of lesional skin diseases such as Verruca vulgaris (common warts and plantar warts) and Molluscum contagiosum.
View company